Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction

Journal of Vascular Surgery

Volumn 64, Issue 2, 2016, Pages 380-388.e1

  Klingelhoefer, Eric ^a,b   Bergert, Hendrik ^a,c   Kersting, Stephan ^a,d   Ludwig, Stefan ^a   Weiss, Norbert ^a   Schönleben, Frank ^e   Grützmann, Robert ^f   Gäbel, Gabor ^a,e  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d Department of General and Vascular Surgery   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

ABOVE KNEE AMPUTATION; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL OUTCOME; CRITICAL LIMB ISCHEMIA; FEMALE; FEMOROPOPLITEAL BYPASS; FOLLOW UP; GERMANY; GRAFT FAILURE; GRAFT PATENCY; HIGH RISK PATIENT; HUMAN; INTERMITTENT CLAUDICATION; INTRAOPERATIVE PERIOD; JOB EXPERIENCE; LIMB SALVAGE; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MINOR SURGERY; OVERALL SURVIVAL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; UNIVERSITY HOSPITAL; VASCULAR SURGEON; ADVERSE EFFECTS; AMPUTATION; BLOOD VESSEL TRANSPLANTATION; CHI SQUARE DISTRIBUTION; CONVALESCENCE; CRITICAL ILLNESS; DIAGNOSTIC IMAGING; GRAFT OCCLUSION, VASCULAR; ISCHEMIA; KAPLAN MEIER METHOD; LOWER LIMB; MORTALITY; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODEL; PROTECTION; RECONSTRUCTIVE SURGERY; RECURRENT DISEASE; REOPERATION; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULARIZATION;

ACADEMIC MEDICAL CENTERS; AGED; AMPUTATION; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; FEMALE; GERMANY; GRAFT OCCLUSION, VASCULAR; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERMITTENT CLAUDICATION; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOGISTIC MODELS; LOWER EXTREMITY; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; RECONSTRUCTIVE SURGICAL PROCEDURES; RECOVERY OF FUNCTION; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84991080797     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2016.02.059     Document Type: Article

References (52)

1. 1 Berglund, J., Bjorck, M., Elfstrom, J., Long-term results of above knee femoro-popliteal bypass depend on indication for surgery and graft-material. Eur J Vasc Endovasc Surg 29 (2005), 412–418.
2. 2 Pereira, C.E., Albers, M., Romiti, M., Brochado-Neto, F.C., Pereira, C.A., Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 44 (2006), 510–517.
3. 3 Solakovic, E., Totic, D., Solakovic, S., Femoro-popliteal bypass above knee with saphenous vein vs synthetic graft. Bosn J Basic Med Sci 8 (2008), 367–372.
4. 4 Green, R.M., Abbott, W.M., Matsumoto, T., Wheeler, J.R., Miller, N., Veith, F.J., et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trial. J Vasc Surg 31 (2000), 417–425.
5. 5 Johnson, W.C., Lee, K.K., A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000), 268–277.
6. 6 Klinkert, P., Schepers, A., Burger, D.H., van Bockel, J.H., Breslau, P.J., Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 37 (2003), 149–155.
7. 7 Diehm, C., Schuster, A., Allenberg, J.R., Darius, H., Haberl, R., Lange, S., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172 (2004), 95–105.
8. 8 Veith, F.J., Gupta, S.K., Ascer, E., White-Flores, S., Samson, R.H., Scher, L.A., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986), 104–114.
9. 9 Michaels, J.A., Choice of material for above-knee femoropopliteal bypass graft. Br J Surg 76 (1989), 7–14.
10. 10 Patterson, R.B., Fowl, R.J., Kempczinski, R.F., Gewirtz, R., Shukla, R., Preferential use of EPTFE for above-knee femoropopliteal bypass grafts. Ann Vasc Surg 4 (1990), 338–343.
11. 11 Prendiville, E.J., Yeager, A., O'Donnell, T.F. Jr., Coleman, J.C., Jaworek, A., Callow, A.D., et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 11 (1990), 517–524.
12. 12 John, T.G., Stonebridge, P.A., Kelman, J., Murie, J.A., Jenkins, A.M., Ruckley, C.V., Above-knee femoropopliteal bypass grafts and the consequences of graft failure. Ann R Coll Surg Engl 75 (1993), 257–260.
13. 13 Archie, J.P. Jr., Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene. Ann Vasc Surg 8 (1994), 475–484.
14. 14 Wilson, Y.G., Wyatt, M.G., Currie, I.C., Baird, R.N., Lamont, P.M., Preferential use of vein for above-knee femoropopliteal grafts. Eur J Vasc Endovasc Surg 10 (1995), 220–225.
15. 15 Koch, G., Gutschi, S., Pascher, O., Fruhwirth, J., Hauser, H., Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen [in German]?. Zentralbl Chir 121 (1996), 761–767.
16. 16 Abbott, W.M., Green, R.M., Matsumoto, T., Wheeler, J.R., Miller, N., Veith, F.J., et al. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group. J Vasc Surg 25 (1997), 19–28.
17. 17 Burger, D.H., Kappetein, A.P., Van Bockel, J.H., Breslau, P.J., A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 32 (2000), 278–283.
18. 18 Devine, C., Hons, B., McCollum, C., Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial. J Vasc Surg 33 (2001), 533–539.
19. 19 Lang, W., Schmidt, O., Radespiel-Tröger, M., Schweiger, H., The above-knee PTFE bypass [in German]. Gefässchirurgie 6 (2001), 34–40.
20. 20 Post, S., Kraus, T., Muller-Reinartz, U., Weiss, C., Kortmann, H., Quentmeier, A., et al. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg 22 (2001), 226–231.
21. 21 Sala, F., Hassen-Khodja, R., Lecis, A., Bouillanne, P.J., Declemy, S., Batt, M., Long-term outcome of femoral above-knee popliteal artery bypass using autologous saphenous vein versus expanded polytetrafluoroethylene grafts. Ann Vasc Surg 17 (2003), 401–407.
22. 22 Tofigh, A.M., Warnier De Wailly, G., Rhissassi, B., Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting. Int J Surg 5 (2007), 109–113.
23. 23 Jensen, L.P., Lepantalo, M., Fossdal, J.E., Roder, O.C., Jensen, B.S., Madsen, M.S., et al. Dacron or PTFE for above-knee femoropopliteal bypass. A multicenter randomised study. Eur J Vasc Endovasc Surg 34 (2007), 44–49.
24. 24 van Det, R.J., Vriens, B.H., van der Palen, J., Geelkerken, R.H., Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial. Eur J Vasc Endovasc Surg 37 (2009), 457–463.
25. 25 Park, K.M., Kim, Y.W., Yang, S.S., Kim, D.I., Comparisons between prosthetic vascular graft and saphenous vein graft in femoro-popliteal bypass. Ann Surg Treat Res 87 (2014), 35–40.
26. 26 Heo, S.H., Park, Y.J., Woo, S.Y., Kim, D.I., Kim, Y.W., Comparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts. Ann Surg Treat Res 88 (2015), 28–34.
27. 27 Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., Inter-society Consensus for the Management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33 (2007), 1–75.
28. 28 Lawall, H., Debus, S., Huppert, P., Kopp, I., Rümenapf, G., Tacke, J., et al. S3 guidelines for diagnostics, treatment and aftercare of peripheral arterial occlusive disease [in German]. Association of the Scientific Medical Societies in Germany (AWMF) - German Society for Angiology - Society for Vascular Medicine, 2015.
29. 29 Pedersen, G., Laxdal, E., Hagala, M., Aune, S., The impact of comorbidity on long-term results of above-knee prosthetic femoropopliteal bypass for intermittent claudication. Int Angiol 24 (2005), 245–249.
30. 30 O'Riordain, D.S., Buckley, D.J., O'Donnell, J.A., Polytetrafluoroethylene in above-knee arterial bypass surgery for critical ischemia. Am J Surg 164 (1992), 129–131.
31. 31 BOA Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355 (2000), 346–351.
32. 32 Belch, J.J., Dormandy, J., Biasi, G.M., Cairols, M., Diehm, C., Eikelboom, B., et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 52 (2010), 825–833.
33. 33 Gassman, A., Degner, B., Al-Nouri, O., Philippi, L., Hershberger, R., Halandras, P., et al. Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency. Vascular 22 (2014), 105–111.
34. 34 Ridker, P.M., Danielson, E., Fonseca, F.A., Genest, J., Gotto, A.M. Jr., Kastelein, J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359 (2008), 2195–2207.
35. 35 Pedersen, T.R., Kjekshus, J., Pyorala, K., Olsson, A.G., Cook, T.J., Musliner, T.A., et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol 81 (1998), 333–335.
36. 36 Henke, P.K., Blackburn, S., Proctor, M.C., Stevens, J., Mukherjee, D., Rajagopalin, S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004), 357–365.
37. 37 Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002), 7–22.
38. 38 Tendera, M., Aboyans, V., Bartelink, M.L., Baumgartner, I., Clement, D., Collet, J.P., et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2851–2906.
39. 39 Hallihan, P.D., Choileain, N.N., Myers, E., Redmond, H.P., Fulton, G.F., Predictors of time to graft failure following infrainguinal arterial reconstruction. Surg Sci 2 (2011), 166–172.
40. 40 Nicholson, M.L., Dennis, M.J., Makin, G.S., Hopkinson, B.R., Wenham, P.W., Obesity as a risk factor in major reconstructive vascular surgery. Eur J Vasc Surg 8 (1994), 209–213.
41. 41 Khandanpour, N., Armon, M.P., Foxall, R., Meyer, F.J., The effects of increasing obesity on outcomes of vascular surgery. Ann Vasc Surg 23 (2009), 310–316.
42. 42 Singh, N., Sidawy, A.N., DeZee, K.J., Neville, R.F., Akbari, C., Henderson, W., Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg 47 (2008), 556–561.
43. 43 Monahan, T.S., Owens, C.D., Risk factors for lower-extremity vein graft failure. Semin Vasc Surg 22 (2009), 216–226.
44. 44 Willigendael, E.M., Teijink, J.A., Bartelink, M.L., Peters, R.J., Buller, H.R., Prins, M.H., Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg 42 (2005), 67–74.
45. 45 Owens, C.D., Ho, K.J., Kim, S., Schanzer, A., Lin, J., Matros, E., et al. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification. J Vasc Surg 45 (2007), 944–952.
46. 46 Evans, L.E., Webster, M.W., Brooks, D.H., Bahnson, H.T., Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up. Surgery 89 (1981), 16–22.
47. 47 Goodney, P.P., Nolan, B.W., Schanzer, A., Eldrup-Jorgensen, J., Bertges, D.J., Stanley, A.C., et al. Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg 24 (2010), 57–68.
48. 48 Wolfle, K.D., Bruijnen, H., Loeprecht, H., Rumenapf, G., Schweiger, H., Grabitz, K., et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. Eur J Vasc Endovasc Surg 25 (2003), 229–234.
49. 49 Conte, M.S., Bandyk, D.F., Clowes, A.W., Moneta, G.L., Seely, L., Lorenz, T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006), 742–751.
50. 50 Setacci, C., de Donato, G., Teraa, M., Moll, F.L., Ricco, J.B., Becker, F., et al. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg 42:Suppl 2 (2011), S43–S59.
51. 51 Faglia, E., Clerici, G., Clerissi, J., Gabrielli, L., Losa, S., Mantero, M., et al. Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study. Diabetes Care 32 (2009), 822–827.
52. 52 Dorigo, W., Pulli, R., Castelli, P., Dorrucci, V., Ferilli, F., De Blasis, G., et al. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics. J Vasc Surg 54 (2011), 1332–1338.